Clinical Trial Update: Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study [Phase 2, Phase 3]

View source ↗

Summary

A randomized, multicenter, double-blind Phase II/III trial evaluating an angiotensin receptor blocker after aortic valve intervention was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Aortic Valve Stenosis, Valsartan | Phase 2, Phase 3 | Status: WITHDRAWN